Penn Medicine Provider
Medical Oncology
Shayma Master Kazmi, MD, RPh
5.0
(806)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Cherry Hill
View 2 additional locations
Make an appointmentCall 800-789-7366

About me

Education and training

  • Medical School: University of Medicine and Dentistry of New Jersey
  • Residency: University Hospital - UMDNJ
  • Residency: Robert Wood Johnson Medical School

What my patients think about me

Average Rating
5.0

808 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
thorough and personable
May 2025
5.0
5.0
very good communication
May 2025
5.0
5.0
she's a good doctor
April 2025
5.0
5.0
very sincere person

Insurance accepted

My Locations

Learn about location
Learn about location
Learn about location

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kazmi is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Kazmi, S The Role of Antibody Drug Conjugates in Non Small Cell Lung Cancer , Oncology Times, 44(2): 2022

Kazmi, S Burnout is Cancer , ASCO Connection: 2021

Kazmi, S, Chatterjee, D, Raju, D, Hauser, R, Kaufman, P Overall Survival Analysis in Patients with metastatic breast cancer and liver or lung metastases treated with Eribulin, Gemcitabine or Capecitabine , Breast Cancer Research and Treatment: 2020

kazmi, S, Wagner, S, Heintzelman, R, Corbman, M Malignant Phyllodes in Lynch Syndrome: a case report , Journal of Medical Case Reports: 2019

Kazmi, S, Ferraro, J My Transformational Experience in a Physician forum group , Oncology Times: 2018

Alvarez, R, et al, Kazmi, S Therapeutic Efficacy of Off label Targeted Agents Utilization Based molecular profiling in advanced cancer patients , ASCO abstract : 2018

kazmi, S A retrospective analysis to evaluate prevalence and correlation between PDL1 score and TMB in patients with solid tumor malignancies , ESMO abstract/poster: 2017

Kazmi, S A retrospective analysis of response to checkpoint inhibitors and its correlation to both PDL1 score and TMB in patients with solid tumor malignancies , ESMO poster/abstract: 2017